Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,474
Closed -$306K 848
2025
Q2
$306K Buy
14,474
+5,365
+59% +$122K ﹤0.01% 1041
2025
Q1
$242K Buy
+9,109
New +$231K ﹤0.01% 1005
2015
Q2
Sell
-9,662
Closed -$236K 1455
2015
Q1
$236K Buy
9,662
+4
+0% +$102 ﹤0.01% 1227
2014
Q4
$245K Buy
9,658
+7
+0.1% +$188 ﹤0.01% 1244
2014
Q3
$273K Hold
9,651
﹤0.01% 1190
2014
Q2
$311K Sell
9,651
-3,267
-25% -$102K ﹤0.01% 1165
2014
Q1
$402K Hold
12,918
﹤0.01% 1117
2013
Q4
$369K Sell
12,918
-9,322
-42% -$301K ﹤0.01% 1125
2013
Q3
$839K Sell
22,240
-30
-0.1% -$1.15K ﹤0.01% 902
2013
Q2
$836K Buy
+22,270
New +$862K ﹤0.01% 873

Other funds holding RYN

Axa's RYN Position: Q3 2025 in Review

Axa sold out of Rayonier (RYN) in Q3 2025, closing a stake of 14,474 shares — an estimated $306K sold.

Axa first reported a position in RYN in Q2 2013 and held it in 10 quarters. The position peaked at $839K in Q3 2013. 367 funds tracked by Wall St. Rank hold RYN as of Q3 2025.

  • Axa reported no remaining Rayonier position as of Q3 2025 after selling out during the quarter.
  • Axa sold 14,474 Rayonier shares in Q3 2025, an estimated $306K.
  • Axa first reported a position in Rayonier in Q2 2013 and held it in 10 quarters.
  • Axa's Rayonier position peaked at $839K in Q3 2013.
  • 367 funds tracked by Wall St. Rank held Rayonier as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.